基石科技(08391.HK)折讓約16.7%配股 最多淨籌約4,712萬元
基石科技控股(08391.HK)公布,擬向最少六名承配人按配售價每股0.4元配售最多4,962.5萬股新股,並再向公司執董及高層管理人員之聯繫人配發6,962.5萬股新股。配售價較公司股份昨日(15日)收市價每股0.48元折讓約16.7%。
配售最多4,962.5萬股新股相當於公司於已發行股本約10.33%;及經擴大已發行股本約9.36%。另外配發6,962.5萬股新股相當於於已發行股本約14.49%;及經擴大後已發行股本約11.61%。
配售及認購事項最多所得款項淨額將約為4,712萬元,擬用於電動車充電業務發展、商業及財經印刷業務、營運資金及一般企業用途。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.